forum

LUPIN Share Price Discussion

Lupin Ltd.
Sector: Pharmaceuticals and health care
... Read more
LUPIN Share Price *
768.7 +4.6 (0.6%)
* (quote may be delayed)

LUPIN Discussion Forum


16-09-19 Intraday BUY LUPIN in cash
only above @ 769.50
Like
reply
Reply (5)
share
Share
Latest replies
Sameer  @tradingfab
Today 2:55 PM

High 770.50 ****
Sameer  @tradingfab
Today 3:02 PM

High 771.80 ****
Sameer  @tradingfab
Today 3:13 PM

High 772.65 ****
Sameer  @tradingfab
Today 3:22 PM

High 774.80 ****
Sameer  @tradingfab
Today 3:25 PM

High 778 ****
Lupin gains on approval from Health Canada for hypertension drug
Lupin says it is the first generic company to get an approval for generic Inderal-LA capsules for the Canadian market.
Moneycontrol
Like
reply
Reply
share
Share
Market Headstart: Nifty seen opening higher; HDFC Bank, Castrol top buys
Trends on SGX Nifty indicate a flat to positive opening for the broader index in India, with a 10 points gain or 0.09 percent. Nifty futures were trading around 11,001.50-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
share
Share

2/4calls + 7/8calls booked profit today 50-90% accuracy today in free service...
TCS 1st Target 2365
Lupin 1st Target 765 done
HDFC booked loss SL done
IndusB booked loss SL done
Loss Recovery Calls for Accuracy Maintain
Yes Bank booked profit near at Target 67
Zeel 1st ( 345 ) ...
Read more...
Like
reply
Reply
share
Share
Lupin exploring in-licensing deals to expand neuro-psychiatry, oncology segments
The company is exploring new product offerings for treating multiple sclerosis, migraine, Parkinson's, and Alzheimer's diseases.
Moneycontrol
Like
reply
Reply
share
Share

2/4calls + 7/8calls booked profit today 50-90% accuracy today in free service...
TCS 1st Target 2..65
Lupin 1st Target 765 done
HDFC booked loss SL done
IndusB booked loss SL done
Loss Recovery Calls for Accuracy Maintain
Yes Bank booked profit near at Target 67
Zeel 1st ( 445 )...
Read more...
Like
reply
Reply
share
Share

LUPIN 767
Like
reply
Reply
share
Share

LUPIN GOT US FDA OK FOR GENERIC OF EDECRIN TABLETS
Like
reply
Reply
share
Share

LUPIN - chart - 347940
LUPIN daily chart. Cup and handle breakout pattern on the chart.
Like
reply
Reply
share
Share

LUPIN - chart - 347692
Lupin Bullish Chart
cmp 773
790 Possible
General View for trading entry exit is important
Like
reply
Reply
share
Share
Lupin gets USFDA nod for chemotherapy-associated nausea and vomiting injection
The company has received approval from the United States Food and Drug Administration (USFDA) for its Fosaprepitant for injection, 150 mg single-dose vial, Lupin said in a statement.
Moneycontrol
Like
reply
Reply
share
Share

LUPIN seems weak below 759 for 754,751.9+
Like
reply
Reply
share
Share
Money guru in LUPIN
Buy Lupin 755

Book profit 765 , this call swing trading
Like
reply
Reply
share
Share
Lupin jumps 2% after Morgan Stanley maintains overweight, sees 32% upside
Lupin entered into a licensing agreement with Germany’s Boehringer Ingelheim to develop and commercialise a novel anti-cancer compound in a deal valued at $700 million.
Moneycontrol
Like
reply
Reply
share
Share
Lupin Ties Up With German Drugmaker Boehringer To Develop, Market Cancer Drugs
The Indian drugmaker said it would receive an upfront payment of $20 million as part of the partnership.
BloombergQuint
Like
reply
Reply
share
Share

BUY LUPIN CASH SEP AT 755 STRICT SL 750 SAFE TRGT 760 FINAL TRGT 764
Like
reply
Reply (1)
share
Share
Latest replies
Commodity Biz @commodityBiz
Sep 5 4:14 PM

BOOK PROFIT IN LUPIN CASH AT 758

Buy Lupin 755
Like
reply
Reply
share
Share

Nomura On Lupin
Maintain Buy, TP Cut To Rs 913 From Rs 1017
US Has Been Disappointing; Low Expectations Make Risk-reward Favourable
Expect Resolution Of Gavis & Indore/Goa Site In FY21
Mkt Not Factoring In Any Meaningful Upside From Innovation, Biosimilar
Like
reply
Reply
share
Share

MS On Lupin
OW, TP Rs 1003
Co Announced Out-licensing Deal With Boehringher Ingelheim (BI) For Oncology Drugs
Estimate 6-7 Yrs To Commercialise These Assets Assuming Successful Clinical/Regulatory Dvpts
Like
reply
Reply
share
Share

LUPIN - 343004

Like
reply
Reply
share
Share

LUPIN - 342997

Like
reply
Reply
share
Share

LUPIN - 341825

Like
reply
Reply
share
Share

Buy lupin above 760 cmp 742
Like
reply
Reply
share
Share
How Lupin's Nagpur facility manages to maintain regulatory compliance
The plant so far had cleared six USFDA inspections with zero observations, including the inspection earlier this month. It was also inspected by UK’s MHRA and WHO, and cleared.
Moneycontrol
Like
reply
Reply
share
Share

*Performance for the WEEK*
*Total notional profits for the WEEK ₹ 3,59,750*
*Futures & Options educational trades for the week 26.8.19 to 30.8.19*
The below trades are given for *educational* purposes and i am not responsible for any losses or profits.
Please note (a) best entry ...
Read more...
Like
reply
Reply
share
Share
Trent: One of the best retail stocks out there
Moneycontrol
Like
reply
Reply
share
Share
Explainer: How Indian pharma companies are riding the biosimilars wave
A Morgan Stanley report says that as many as nine biologic drugs have either gone off patent or will do so by 2025, with combined revenues of $62 billion in 2018.
Moneycontrol
Like
reply
Reply
share
Share
Nearly 30 stocks saw FY20 EPS downgrades in last 4 qtrs; time to exit?
Most brokerage firms have downgraded EPS estimates for Nifty. There are as many as 28 stocks in BSE100 that saw FY20 EPS downgrades in the last four quarters
Moneycontrol
Like
reply
Reply
share
Share
Market Headstart: Nifty seen opening higher; Axis Bank, D-Mart top buys
Trends on SGX Nifty indicate a positive opening for the broader index in India, with 0.17 percent gain or 19 points. Nifty futures were trading around 11,071-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
share
Share

*Performance on day ONE*
*Futures & Options educational trades for the week 26.8.19 to 30.8.19*
The below trades are given for *educational* purposes and i am not responsible for any losses or profits.
Please note (a) best entry is taken on day 1 (b) the high/low achievement of t...
Read more...
Like
reply
Reply
share
Share

LUPIN - 327759
"Lupin subsidiary in South Africa announces Commercial Agreement with Creso Pharmafor hemp oil based cannaQIX??".
Like
reply
Reply
share
Share
Equity commodities in LUPIN
15 NOW🚀🚀🚀

15 NOW🚀🚀🚀
Like
reply
Reply
share
Share
Equity commodities in LUPIN
Buy lupin 750 ce @ 9 Aug exp

15 NOW🚀🚀🚀
Like
reply
Reply
share
Share
Umanath
Lupin sell @743 SL 751 target 736

Lupin 735 low. Target achieved. If traded put me screenshots in reply corner
Like
reply
Reply
share
Share

*Futures & Options educational trades for the week 26.8.19 to 30.8.19*
The below trades are given for *educational* purposes and i am not responsible for any losses or profits.
Please note (a) best entry is taken on day 1 (b) the high/low achievement of the week is taken for calc...
Read more...
Like
reply
Reply
share
Share

Buy lupin 750 ce @ 9
Aug exp
Like
reply
Reply
share
Share
Market Headstart: Nifty likely to open flat; Ashok Leyland, Bank of India top sell ideas
Trends on SGX Nifty indicate a negative opening for the broader index in India, with 0.08 percent loss or 9 points. Nifty futures were trading around 10,716-level on the Singaporean Exchange.
Moneycontrol
Like
reply
Reply
share
Share

Economic Times
Business Standard
Ø India's consumer confidence drops in August: Report
Ø Airtel fastest mobile broadband network, Jio now slowest
Ø Startups with turnover up to Rs 25 cr to get tax break
Ø Gadkari eyes Rs 10L crore revenue from Bharatcraft
Ø Labour code on m...
Read more...
Like
reply
Reply
share
Share
Lupin launches generic antidepressant tablets in US
The product is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, it added.
Moneycontrol
Like
reply
Reply
share
Share
rajiv kumar jha in LUPIN
Lupin buy@738 Sl 729 q-100/200

745 👈😁
Like
reply
Reply
share
Share
Lupin to divest its Japanese injectables biz to Neopharma group
"Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo ALA Co Ltd. The transaction is subject to customary closing conditions and has been approved by the board of directors of Lupin," Lupin said in a regulatory filing.
Moneycontrol
Like
reply
Reply
share
Share
Lupin gains on sale of Japanese injectables business
The transaction is subject to customary closing conditions and has been approved by the board of directors of Lupin.
Moneycontrol
Like
reply
Reply
share
Share
These 7 'lucky' stocks saw EPS upgrades in last 3 of 4 quarters; time to buy?
Investors should pick those stocks which are displaying signs of consistent growth.
Moneycontrol
Like
reply
Reply
share
Share

Lupin buy@738
Sl 729 q-100/200
Like
reply
Reply
share
Share

Intraday lupin fut sell 742
Sl-745
Trg-+1/+3/+5🔥🔥🔥😂
Like
reply
Reply (1)
share
Share
Latest replies
Rajmudra Stock @rajmudra
Aug 21 4:37 PM

All target achieve book profit and exit 🥰🥰😘

Lupin fut buy 740
Sl-729
Trg-745/750/760/765++
Hold 4/6 days🔥🔥🚀
Like
reply
Reply
share
Share

levels in lupin
Level 1 - buy abv 746 for 748 750 752
Level 2 - sell blw 725 for 723 721 719
sl 4 points in both
Like
reply
Reply (1)
share
Share
Latest replies

First trgt achieved 👍👍👍
High made 748.05
1400 profit
Small Traders can book profit or shift sl
Money Market Operations as on February 20, 2014
Money Market Operations as on February 20, 2014
moneycontrol.com
Like
reply
Reply
share
Share
Buy Lupin; target of Rs 885: Motilal Oswal
Motilal Oswal is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 885 in its research report dated August 08, 2019.
www.moneycontrol.com
Like
reply
Reply
share
Share
Surprise or disappointment in Q1: Here’s how top companies have performed this week
Experts say that there is a possibility double-digit earnings growth could be seen after the September quarter
www.moneycontrol.com
Like
reply
Reply
share
Share
  • LUPIN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization33,444.28
    Enterprise Value33,384.84
    Price to Earnings24.77
    Price to Book Value1.95
    Return on Capital Employed0.12
    Return on Equity0.09
    Face Value2
    Dividend Yield0.01
  • LUPIN Share Price - Technicals

    keyboard_arrow_down
    LUPIN - 52 Week High₹978
    LUPIN - 52 Week Low₹697.2
  • LUPIN - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    9-Aug-19Prabhudas LilladherReduce730
    8-Aug-19Karvy Stock BrokingHold861
    19-Jul-19EdelweissBuy900
    17-May-19HDFC SecuritiesBuy930
    16-May-19Prabhudas LilladherReduce730
    View all LUPIN - Share Targets - Broker Reports
  • LUPIN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 16764.1780760.7769.15
    Sep 13762.4766753.6764.1
    Sep 12762.8767.9754.75759.05
    Sep 11767769756759.55
    Sep 9772778.65764.5766.7
  • LUPIN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹746.86
    30 Day Moving Average₹750.67
    50 Day Moving Average₹753.19
    100 Day Moving Average₹765.36
    200 Day Moving Average₹791.7
  • LUPIN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue10,08012,753.15-0.21
    Operating Profit2,0864,486.12-0.54
    Profit Before Tax1,7934,179.06-0.57
    Net Income1,3443,141.33-0.57
  • LUPIN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds17,11715,7840.08
    Total Liabilities2,5733,042-0.15
    Total Assets19,69018,8270.05
  • LUPIN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2154,353.33-0.95
    Cash from Investing Activity-1,159-1,941.79-0.4
    Cash from Financing Activity-986-160.025.16
    Net Cash Flow-1,9312,251.52-1.86
  • LUPIN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.070.17
    Return on Equity0.090.21
    Return on Capital Employed0.120.27
  • LUPIN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.03
    3 Year CAGR Growth in Operating Profit-0.38
    3 Year CAGR Growth in EBIDTA-0.38
    3 Year CAGR Growth in Net Income-0.44
    3 Yr CAGR Growth - Diluted EPS-0.44
  • LUPIN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.42
    5 Year CAGR Growth in Operating Profit0.11
    5 Year CAGR Growth in EBIDTA0.16
    5 Year CAGR Growth in Net Income0.07
    3 Yr CAGR Growth - Diluted EPS0.06
  • LUPIN Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 13 9:13 PM
    Lupin gains on approval from Health Canada for hypertension drug
    Moneycontrol
    NewsBot
    Sep 13 2:23 PM
    Market Headstart: Nifty seen opening higher; HDFC Bank, Castrol top buys
    Moneycontrol
    NewsBot
    Sep 12 11:43 PM
    Lupin exploring in-licensing deals to expand neuro-psychiatry, oncology segments
    Moneycontrol
    NewsBot
    Sep 6 9:38 PM
    Lupin gets USFDA nod for chemotherapy-associated nausea and vomiting injection
    Moneycontrol
    NewsBot
    Sep 5 4:48 PM
    Lupin jumps 2% after Morgan Stanley maintains overweight, sees 32% upside
    Moneycontrol
    NewsBot
    Aug 31 3:53 AM
    How Lupin's Nagpur facility manages to maintain regulatory compliance
    Moneycontrol
    NewsBot
    Aug 28 3:38 PM
    Trent: One of the best retail stocks out there
    Moneycontrol
    NewsBot
    Aug 28 2:08 AM
    Explainer: How Indian pharma companies are riding the biosimilars wave
    Moneycontrol
    NewsBot
    Aug 27 3:38 PM
    Nearly 30 stocks saw FY20 EPS downgrades in last 4 qtrs; time to exit?
    Moneycontrol
    NewsBot
    Aug 27 2:33 PM
    Market Headstart: Nifty seen opening higher; Axis Bank, D-Mart top buys
    Moneycontrol
  • LUPIN - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.